Mobius Therap Drug Patent Portfolio
Mobius Therap owns 1 orange book drug protected by 5 US patents Given below is the list of Mobius Therap's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649428 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 21 May, 2029 | Active |
| US7806265 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 01 Feb, 2029 | Active |
| US9539241 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 02 Jan, 2028 | Active |
| US8186511 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 19 Jul, 2026 | Active |
| US9205075 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application | 19 Jul, 2026 | Active |
Latest Legal Activities on Mobius Therap's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mobius Therap.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 10 Jul, 2024 | US9539241 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 23 Oct, 2023 | US8186511 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 08 Jun, 2023 | US9205075 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 05 Apr, 2022 | US7806265 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 16 Nov, 2020 | US9649428 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 10 Jul, 2020 | US9539241 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 23 Oct, 2019 | US8186511 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 10 Jun, 2019 | US9205075 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 05 Apr, 2018 | US7806265 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 30 Mar, 2018 | US9205075 |
|
Email Notification
Critical
| 29 Mar, 2018 | US9205075 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Mar, 2018 | US9205075 |
|
Correspondence Address Change
Critical
| 28 Mar, 2018 | US9205075 |
|
Recordation of Patent Grant Mailed
Critical
| 16 May, 2017 | US9649428 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 16 May, 2017 | US9649428 |
Mobius Therap's Family Patents
Mobius Therap drugs have patent protection in a total of 5 countries. It's US patent count contributes only to 50.0% of its total global patent coverage. Click
below to unlock the full patent family tree.
Mobius Therap Drug List
Given below is the complete list of Mobius Therap's drugs and the patents protecting them.
1. Mitosol
Mitosol is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649428 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
21 May, 2029
(4 years from now)
| Active |
| US7806265 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
01 Feb, 2029
(4 years from now)
| Active |
| US9539241 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
02 Jan, 2028
(3 years from now)
| Active |
| US8186511 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
19 Jul, 2026
(1 year, 6 months from now)
| Active |
| US9205075 | Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application |
19 Jul, 2026
(1 year, 6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mitosol's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List